Tetanus is a serious neurological disease caused by tetanospasmin, a potent neurotoxin produced by Clostridium tetani. The bacterium is an anaerobic, Gram-positive, spore-forming organism whose spores are widely distributed in soil, dust and environmental material. Unlike many infections transmitted directly from person to person, Tetanus is generally acquired when spores contaminate a wound and germinate under conditions that permit bacterial growth. The disease is characterised by sustained muscle rigidity and painful spasms caused by toxin-mediated disruption of inhibitory neurotransmission. The name derives from the Greek tetanos, referring to tension or stretching. Tetanus is preventable through vaccination and appropriate wound management, but established disease can be life-threatening.
C. tetani spores can enter the body through puncture wounds, lacerations, burns, crush injuries, surgical wounds or other breaks in the skin. A wound does not have to contain visible soil to provide a route for infection, and apparently minor injuries can occasionally be relevant. Anaerobic conditions, tissue damage and foreign material can facilitate germination. Tetanus is not normally transmitted from an infected person to another person. This distinction is important because vaccination protects individuals from toxin-mediated disease rather than preventing person-to-person spread. Neonatal Tetanus can occur when spores contaminate the umbilical stump under unsafe delivery or cord-care conditions, particularly where maternal immunity is inadequate.
Tetanospasmin reaches the nervous system and interferes with inhibitory neurotransmission by preventing the release of neurotransmitters such as gamma-aminobutyric acid and glycine from inhibitory interneurons. Loss of inhibitory control causes excessive and sustained motor-neuron activity. Clinically, this produces muscle rigidity and spasms rather than paralysis caused by failure of motor transmission. Trismus, commonly called lockjaw, is a characteristic early manifestation. Other findings can include difficulty swallowing, abdominal rigidity, risus sardonicus, generalised spasms and autonomic instability. Stimuli such as noise, touch or sudden movement can trigger severe spasms in susceptible patients.
Generalised Tetanus is the most common clinical form and can involve widespread rigidity, recurrent spasms and autonomic disturbances. Localised Tetanus affects muscles near the site of injury and can sometimes progress to generalised disease. Cephalic Tetanus is a rare form associated with cranial-nerve dysfunction, often following head or facial injury or certain ear conditions. Neonatal Tetanus presents in newborns, typically after an initially normal period followed by difficulty feeding, irritability, rigidity and spasms. The clinical forms differ in presentation but share the fundamental mechanism of toxin-mediated loss of inhibitory neurological control.
Diagnosis of Tetanus is primarily clinical because there is no routinely useful laboratory test that can reliably exclude the disease. A history of a potentially contaminated wound or incomplete vaccination strengthens suspicion but is not required, because the wound may be unnoticed or healed by the time symptoms appear. Laboratory cultures from wounds have limited sensitivity and a positive culture does not necessarily establish that clinically significant toxin has been produced. Conversely, absence of C. tetani from a wound does not rule out Tetanus. Recognition of characteristic rigidity and spasms is therefore central to diagnosis, and treatment should not be delayed while seeking confirmatory testing.
Treatment involves neutralising unbound toxin, eliminating the bacterial source, controlling spasms and supporting vital functions. Human tetanus immune globulin can neutralise circulating toxin that has not yet bound to nervous tissue. Wound cleaning and debridement can remove necrotic tissue and material supporting bacterial growth, while appropriate antibiotics may reduce the bacterial burden. Severe disease can require intensive care, airway support, sedation, muscle-relaxing treatment and management of autonomic instability. Recovery can be prolonged because the nervous system must restore normal function after toxin effects have occurred. Importantly, surviving Tetanus does not reliably produce protective immunity, so vaccination is still required after recovery.
Prevention relies heavily on vaccination with Tetanus toxoid, usually delivered as part of combination vaccines. Because protection can decline with time, booster vaccination is recommended according to national schedules and individual circumstances. Wound management can involve assessment of vaccination history and the nature of the wound, with additional vaccine and, in selected circumstances, tetanus immune globulin used when risk is significant and immunity is inadequate. Maternal vaccination is important in preventing neonatal disease because maternal antibodies can provide passive protection to the newborn. Improvements in vaccination coverage, sterile obstetric practices and wound care have greatly reduced Tetanus incidence in many countries.
Tetanus differs fundamentally from Diphtheria and other communicable bacterial diseases because ordinary transmission does not occur between people. The disease results from environmental spores entering tissue and subsequently producing toxin. Another common misconception is that a visibly rusty object itself causes Tetanus; rust is not the causative agent, although objects contaminated with environmental material can create puncture wounds through which spores enter. Tetanus remains significant because spores are environmentally persistent and vaccination prevents disease but does not remove environmental exposure. Maintaining immunity and appropriately managing wounds therefore remain necessary even where Tetanus is uncommon.
